• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三磷酸鸟苷酶作为结核病治疗的新靶点。

Guanosine triphosphatases as novel therapeutic targets in tuberculosis.

机构信息

Institute of Genomics and Integrative Biology, Mall Road, Delhi, India.

出版信息

Int J Infect Dis. 2010 Aug;14(8):e682-7. doi: 10.1016/j.ijid.2009.11.016. Epub 2010 Mar 6.

DOI:10.1016/j.ijid.2009.11.016
PMID:20207570
Abstract

Tuberculosis (TB) is an infectious disease caused by the aerobic microbe Mycobacterium tuberculosis H(37)Rv. Despite the availability of the Bacille Calmette-Guérin (BCG) vaccine and directly observed treatment, short-course (DOTS), TB is a leading cause of death and affects a third of the world's population. The most important factor associated with disease severity is the development of antibiotic-resistant strains, including multidrug-resistant (MDR)-TB and extensively drug-resistant (XDR)-TB. In order to understand disease pathogenesis, it is necessary to delineate the specific features of M. tuberculosis that enable it to evade the host defense system and contribute to its virulence. Here, we have reviewed the various characteristics, such as cell wall components, virulence genes, and the role of small guanosine triphosphatases (GTPases) in the pathogenesis of TB. GTPases are known to play a crucial role in the survival and pathogenesis of various pathogens. The key role of these proteins involves interference in phagosome maturation arrest, enabling pathogens to survive by escaping from lysozymes and toxic free radicals. This observation provides a new avenue for the development of anti-TB drugs.

摘要

结核病(TB)是一种由需氧微生物结核分枝杆菌 H(37)Rv 引起的传染病。尽管有卡介苗(BCG)疫苗和直接观察治疗短期疗程(DOTS),但结核病仍然是导致死亡的主要原因之一,影响了世界上三分之一的人口。与疾病严重程度最相关的最重要因素是抗生素耐药菌株的发展,包括耐多药(MDR)-TB 和广泛耐药(XDR)-TB。为了了解疾病的发病机制,有必要描绘使结核分枝杆菌能够逃避宿主防御系统并有助于其毒力的特定特征。在这里,我们综述了细胞壁成分、毒力基因以及小 GTP 酶在结核病发病机制中的作用等各种特征。众所周知,GTP 酶在各种病原体的存活和发病机制中起着至关重要的作用。这些蛋白质的关键作用涉及干扰吞噬体成熟的停滞,使病原体通过逃避溶菌酶和有毒自由基而存活。这一观察为开发抗结核药物提供了新途径。

相似文献

1
Guanosine triphosphatases as novel therapeutic targets in tuberculosis.三磷酸鸟苷酶作为结核病治疗的新靶点。
Int J Infect Dis. 2010 Aug;14(8):e682-7. doi: 10.1016/j.ijid.2009.11.016. Epub 2010 Mar 6.
2
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
3
[Frontier of mycobacterium research--host vs. mycobacterium].[分枝杆菌研究前沿——宿主与分枝杆菌]
Kekkaku. 2005 Sep;80(9):613-29.
4
Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.肺切除术联合基于异烟肼和利福平的药物治疗用于耐多药和广泛耐药结核病患者。
Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.
5
Extensively drug-resistant tuberculosis in california, 1993-2006.1993 - 2006年加利福尼亚州的广泛耐药结核病
Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.
6
Extensively drug-resistant tuberculosis: new strains, new challenges.广泛耐药结核病:新菌株,新挑战。
Expert Rev Anti Infect Ther. 2008 Oct;6(5):713-24. doi: 10.1586/14787210.6.5.713.
7
Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.未感染艾滋病毒的耐多药和广泛耐药结核病患者的治疗结果。
Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005.
8
Mechanisms of drug resistance in Mycobacterium tuberculosis.结核分枝杆菌耐药机制。
Int J Tuberc Lung Dis. 2009 Nov;13(11):1320-30.
9
First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.伊朗国家结核病转诊中心一线抗结核药物耐药模式及趋势——八年监测情况
Int J Infect Dis. 2009 Sep;13(5):e236-40. doi: 10.1016/j.ijid.2008.11.027. Epub 2009 Mar 13.
10
Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.肽脱甲酰基酶——结核病治疗及抗菌药物研发的一个有前景的治疗靶点。
Expert Opin Ther Targets. 2009 Jul;13(7):753-65. doi: 10.1517/14728220903005590.

引用本文的文献

1
Structural and functional characterization of mycobacterial PhoH2 and identification of potential inhibitor of its enzymatic activity.结核分枝杆菌 PhoH2 的结构与功能表征及其酶活性潜在抑制剂的鉴定。
Braz J Microbiol. 2024 Jun;55(2):1033-1051. doi: 10.1007/s42770-024-01267-4. Epub 2024 Feb 22.
2
Computational evaluation of anticipated PE_PGRS39 protein involvement in host-pathogen interplay and its integration into vaccine development.预期的PE_PGRS39蛋白在宿主-病原体相互作用中的作用及其在疫苗开发中的整合的计算评估。
3 Biotech. 2021 Apr;11(4):204. doi: 10.1007/s13205-021-02746-3. Epub 2021 Apr 1.
3
Structural Prediction and Mutational Analysis of Rv3906c Gene of HRv to Determine Its Essentiality in Survival.
人型结核分枝杆菌Rv3906c基因的结构预测与突变分析以确定其在生存中的必要性
Adv Bioinformatics. 2018 Aug 15;2018:6152014. doi: 10.1155/2018/6152014. eCollection 2018.
4
Host-directed therapeutics for tuberculosis: can we harness the host?结核病的宿主导向治疗:我们能否利用宿主?
Microbiol Mol Biol Rev. 2013 Dec;77(4):608-27. doi: 10.1128/MMBR.00032-13.
5
Drug-resistant tuberculosis: emerging treatment options.耐药结核病:新出现的治疗选择
Clin Pharmacol. 2011;3:51-67. doi: 10.2147/CPAA.S11597. Epub 2011 Dec 14.
6
Multidrug and extensively drug-resistant tuberculosis from a general practice perspective.全科视角下的耐多药和广泛耐药结核病。
Infect Drug Resist. 2010;3:115-22. doi: 10.2147/IDR.S10743. Epub 2010 Oct 22.
7
Major prospects for exploring canine vector borne diseases and novel intervention methods using 'omic technologies.利用“组学”技术探索犬媒介传染病和新型干预方法的主要前景。
Parasit Vectors. 2011 Apr 13;4:53. doi: 10.1186/1756-3305-4-53.